The aim of the present study was tochecked the compatibility between drug: lipid and drug: excipients. Ellagic acid was selected as model drug while phospholipid and Cholesterol were considered excipients. The study was performed by Fourier transform infrared spectroscopy 
Introduction
The drug and excipients compatibility study first require an aforementioned acquaintance of physicochemical properties for the development of pharmaceutical formulation Despite the significance of the dispute, there is no universal recognized protocol for drug-excipients incompatibility testing 6, 7 .
Ellagic acids have potent antioxidant activity and it is use in some various diseases like cancer, wound healing, ulcer etc. 8 . In recent years, nanostructured materials such as nanoparticles, liposomes etc., have been considered as potential carriers for hydrophobic drug delivery that may purpose the above mentioned complications 9, 10 .
Novel liposomal carrier developing a significant part of research in the field of drug delivery because they have ability to distribute an extensive assortment of drugs to various parts of the body for sustained periods of time. Liposomal novel carrier systems are actively investigated as drug carriers to reduce drug toxicity and degradation, and it deliver therapeutic agents to several sites of action to promote a suitable, selective and specific targeted therapy 12 DSC technique involves the application of a heating or cooling signal to a sample and a reference. When the substance goes through a thermal event, the variance in heat flow to sample and reference is observed against time and temperature. Consequently, it can be concluded that energy is associated with various thermal events including melting, glass transition temperature and crystallization etc.
Apart from DSC, FTIR Spectroscopy was used as another technique to determine the hypothesized compatibility study between drug and excipients which result that same functional group was changed as compared to standard FTIR Spectra of drug and excipients due to incompatibility between drug and excipients formulation. This interaction study was done by using DSC, FTIR and HPLC.
Materials and Methods

Materials
Quercetin, phosphatidylcholine and cholesterol were purchased from Hi-media chemicals Mumbai, India. HPLC grade solvents were purchased from Merck Mumbai, India. All other materials and solvents used were of analytical grade.
Sample preparation
The quercetin, phospholipid and cholesterol mixtures prepared at 1:1:1 ratio. The quercetin, phospholipid and cholesterol were individually weighed in a 10 ml glass vial and mixed on a vortex mixer for 2 min. In each of the vials, 10% of the water was added and the drug-excipient blend was further mixed. Each vial was sealed Teflon-lined screw cap and stored at 50 °C for 4 weeks.
These samples were periodically examined for any change of unusual color change. 
Fourier transforms infrared radiation measurement (FTIR)
FTIR spectra's were recorded on a FTIR spectroscopy using the instrument Shimadzu FT-IR 8400S in the frequency range of 400- 
Differential Scanning Calorimetry (DSC)
Differential Scanning Calorimetry (Perkin Elmer Jade, California, USA, department of pharmaceutical sciences dibrugarh university, Assam, India) was used for thermal analysis of drug and mixture of drug and excipients in a 1:1 w/w ratio. Individual samples (drug and excipients) as well as physical mixture of drug and excipients were weighed to about 5mg in DSC aluminum pan. The sample pan was crimped for effective heat conduction and scanned in the temperature range of 50-300°C. Heating rate of 20°C min-1 was used and the thermogram obtained was reviewed for evidence of any interactions.
Results and Discussion
Drug content estimation by HPLC
The ellagic acid and excipients mixture was physically observed at different intervals. No Characteristic color change were observed.
The assay of the drug excipients mixtures were found good. Assay for ellagic acid, phospholipid and cholesterol respectively. The findings indicate no interference between ellagic acid and excipient (Table 2 ). There was no major changes in peaks of ketone (C=O) and hydroxyl (O-H) in reference to the observed value of elllagic acid.
DSC
The DSC thermogram corresponding to quercetin, phospholipid and physical mixture are shown in Figure 3 . Ellagic acid exhibits a characteristic endothermic peak at 260.44°C corresponding to its melting temperature. A broad endothermic band from 158.6°C was observed for the amorphous phospholipid, which was related to loss of water molecules i.e., dehydration process. The DSC thermogram for the solid complex of ellagic acid, phospholipid and cholesterol showed an endothermic peak at 147.5°C associated with the formation of complex in the solid state. As such there is no interaction between ellagic acid, phospholipid and cholesterol. 
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